Has Jeffrey Thompson, DO received payments from drug or device companies?

Yes. Drug and device makers reported $81,152 in general payments to Jeffrey Thompson, DO across 64 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Jeffrey Thompson, DO did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Jeffrey Thompson, DO come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Jeffrey Thompson, DO

Orthopaedic Surgery of the Spine · Massapequa, NYNPI 1265895213

Payments from drug & device makers

What this record shows

This record is dominated by grants: $75,000 of the $81,152 with a category attached, or 92.4%. Medtronic accounts for 94.5% of it on its own, with 18 other manufacturers making up the rest. Reporting peaked in 2021 at $75,529 and has fallen 97.2% since, to $2,120 in 2025.

$81,152in general payments, 2019–2025

Across 64 payments — averaging $1268.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Medtronic$77K
Stryker$2K
Medical Device Business Services, Inc.$981
Johnson & Johnson$486
Arteriocyte Medical Systems, Inc.$288
Spinal Elements, Inc.$273
plus $746 from 13 others

What the payments were for

Consulting fees$9301%
Grants$75,00092%
Travel & lodging$1,2332%
Food & beverage$3,9895%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Medtronic	19	$76,668
Stryker	10	$1,709
Medical Device Business Services, Inc.	2	$981
Johnson & Johnson	6	$486
Arteriocyte Medical Systems, Inc.	1	$288
Spinal Elements, Inc.	12	$273
Zimmer Biomet	1	$132
Orthofix Medical, Inc.	2	$125
Spine Wave, Inc.	1	$110
Zimvie Inc.	1	$71
Biocomposites Inc	1	$59
Precision Spine, Inc.	1	$51
DJO, LLC	1	$46
Boston Scientific	1	$36
Globus Medical	1	$28
Vertex	1	$28
Fidia Pharma USA Inc.	1	$25
Life Spine, Inc.	1	$18
Heron Therapeutics, Inc.	1	$17

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Mazor X Stealth Edition$75,111
ES2 SPINAL SYSTEM$954
EVEREST SPINAL SYSTEM$338
ARTIC-L 3D TI SPINAL SYSTEM WITH TIONIC TECHNOLOGY$333
Magellan$288
MAZOR X SYSTEM$282
Medical Devices$265
CD HORIZON$261
ANTERALIGN SPINAL SYSTEM WITH TITAN NANOLOCK SURFACE TECHNOLOGY$194
TRITANIUM$173
SERRATO$173
OZARK CERVICAL PLATE SYSTEM$173
AERO-LL$172
SYMPHONY$150
mymobility Platform$132
CATALYFT PL EXPANDABLE INTERBODY SYSTEM$116
VA-LCP$114
SPINAL IMPLANT$110
GAMMA$110
INCEPTIV$110

How this compares

$81,152 in reported general payments places this provider in the 75th percentile of 161 orthopaedic surgery of the spine providers in New York.

See all orthopaedic surgery of the spine providers in New York →

Medicare billing

Part B allowed, 2024

$108,869

Medicare patients

120

Services billed

472

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Cyclobenzaprine Hcl	32	$310
Methocarbamol	11	$137
Meloxicam	34	$103
Naproxen	17	$42

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery of the spine in Massapequa

Hansen YuanSyracuse$31.7M
Frank SchwabNew York$5.1M
Han KimNew York$3.9M
Todd AlbertNew York$2.7M
Jeffrey SpivakNew York$1.3M
Aaron BucklandNew York$1M
Seth NeubardtWhite Plains$902K
Sheeraz QureshiNew York$828K
Jeffrey GoldsteinNew York$765K
Fabien BitanNew York$624K

See the full list for New York →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →